EXCEED THE SPACE PROVIDED. Dominant mechanisms of tolerance have obvious therapeutic implications for intervention in autoimmunity and transplant-rejection. Our knowledge of how 'regulatory' T (Treg) cells are induced and their mode of action is largely derived from studies of polyclonal T cell responses. The exact nature of the cellular interactions that govern the generation and homeostasis of regulatory T cells remains elusive and is subject of the present proposal. We will make use of two double-transgenic models that share an MHC class II restricted T cell receptor (TCR) specific for influenza hemagglutinin (HA), while the model antigen HA is expressed rather ubiquitously in one system and in a 'tissue-specific' fashion in the other system. In both models, we have observed 'anergic' CD4 T cells that can suppress the response of na'fve CD4 T cells in vitro. The regulatory properties of TCR transgenic CD4 T cells segregate with the expression of CD25 only in one system, while in the other CD25 negative cells are likewise inhibitory. Intriguingly, thymic epithelium is involved in the generation of regulatory cells not only in the situation of widespread antigen expression, but likewise when antigen expression is driven by a 'tissue-specific' promoter, the latter being reminiscent of 'promiscuous' expression of tissue-antigens in thymic epithelial cells. Both transgenic systems will be employed and compared with respect to the role of hematopoietic versus thymic epithelial cells in the generation of Treg cells and to address questions concerning the antigen-dependency of thymus derived Treg cells after exit from the thymus. Furthermore, we will test the hypothesis that 'promiscuous' expression of so-called tissue-antigens in thymic epithelium is involved in the generation of Treg cells. Ultimately, based on the observations in our transgenic systems, we will test lifferent protocols to experimentally induce Treg cells in vivo. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI053102-03
Application #
6832874
Study Section
Immunobiology Study Section (IMB)
Program Officer
Macchiarini, Francesca
Project Start
2002-12-01
Project End
2007-11-30
Budget Start
2004-12-01
Budget End
2005-11-30
Support Year
3
Fiscal Year
2005
Total Cost
$554,225
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Schlenner, Susan M; Weigmann, Benno; Ruan, Qingguo et al. (2012) Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. J Exp Med 209:1529-35
Daniel, Carolin; Weigmann, Benno; Bronson, Roderick et al. (2011) Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope. J Exp Med 208:1501-10
Daniel, Carolin; Ploegh, Hidde; von Boehmer, Harald (2011) Antigen-specific induction of regulatory T cells in vivo and in vitro. Methods Mol Biol 707:173-85
Daniel, Carolin; von Boehmer, Harald (2011) Extra-thymically induced regulatory T cells: do they have potential in disease prevention? Semin Immunol 23:410-7
Daniel, Carolin; von Boehmer, Harald (2011) Extrathymic generation of regulatory T cells--chances and challenges for prevention of autoimmune disease. Adv Immunol 112:177-213
von Boehmer, Harald; Melchers, Fritz (2010) Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol 11:14-20
Daniel, Carolin; Wennhold, Kerstin; Kim, Hye-Jung et al. (2010) Enhancement of antigen-specific Treg vaccination in vivo. Proc Natl Acad Sci U S A 107:16246-51
Feuerer, Markus; Hill, Jonathan A; Kretschmer, Karsten et al. (2010) Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc Natl Acad Sci U S A 107:5919-24
Merkenschlager, Matthias; von Boehmer, Harald (2010) PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors. J Exp Med 207:1347-50
von Boehmer, Harald (2009) Central tolerance: essential for preventing autoimmune disease? Eur J Immunol 39:2313-6

Showing the most recent 10 out of 18 publications